Table 2 MNCP assay bacterial identification and concordance rate with the conventional method and Sanger sequencing.

From: Evaluation of a micro/nanofluidic chip platform for diagnosis of central nervous system infections: a multi-center prospective study

Microorganism

Sanger sequencing

Conventional methods

Error

No-detected

MNCP-II

Concordance rate

Gram Positive Bacteria

55

55

5

1

49

89.09%

Enterococcus faecalis

5

5

1

0

4

80.00%

Enterococcus faecium

4

4

1

0

3

75.00%

Staphylococcus aureus

9

9

1

0

8

88.89%

Staphylococcus capitis

4

4

1

0

3

75.00%

Staphylococcus epidermidis

14

14

0

0

14

100.00%

Staphylococcus haemolyticus

1

1

0

0

1

100.00%

Staphylococcus hominis

6

6

0

0

6

100.00%

Streptococcus agalactiae

8

8

0

1

7

87.50%

Streptococcus pneumoniae

4

4

1

0

3

75.00%

Gram Negative Bacteria

119

119

6

5

108

90.76%

Acinetobacter baumannii

42

42

2

2

38

90.48%

Enterobacter aerogenes

3

3

0

0

3

100.00%

Enterobacter cloacae

5

5

1

0

4

80.00%

Escherichia coli

11

11

1

2

8

72.73%

Haemophilus influenzae

2

2

0

0

2

100.00%

Klebsiella pneumoniae

29

29

2

1

26

89.66%

Pseudomonas aeruginosa

26

26

0

0

26

100.00%

Stenotrophomonas maltophilia

1

1

0

0

1

100.00%

Fungus

5

5

0

1

4

80.00%

Candida albicans

3

3

0

1

2

66.67%

Candida glabrata

2

2

0

0

2

100.00%

Total

180

180

11

7

162

90.00%